| Literature DB >> 36033330 |
Qiao Feng Wang1, Li Jun Liang2, Jiang Bing Sun2, Jun Zhou2.
Abstract
A simple and efficient sample extraction and preconcentration method based on reversed-phase ionic liquid dispersive liquid-liquid microextraction (RP-IL-DLLME) had been developed and used to quantify the domoic acid in human urine samples. The analysis was performed by ultra-performance liquid chromatography and photodiode array detection. During the procedure, hydrophilic ionic liquid 1-butyl-3-methylimidazolium tetrafluoroborate [C4mim] BF4 as dispersive solvent and NaOH solution was chosen as extraction solvent. Some important parameters in the method were investigated to get high enrichment factors. Under optimal conditions, the linearity of the method was in the range of 0.1-10 ng mL-1 and the correlation coefficient was above 0.9996. The relative standard deviations (RSDs) of the developed methods for intra-day (n = 5) and inter-day (n = 5) precision ranged from 1.9 to 3.9%. Meanwhile, limit of detection (LOD) was 0.03 ng mL-1(S/N = 3) and that of quantification (LOQ) was 0.1 ng mL-1(S/N = 10) with the enrichment factors (EF) being 230. Eventually, the proposed method was successfully applied to the determination of Dominic acid in human urine samples.Entities:
Keywords: Domoic acid; Ionic liquid; Reversed-phase dispersive liquid-liquid microextraction; Ultra-high-performance liquid chromatography
Year: 2022 PMID: 36033330 PMCID: PMC9404275 DOI: 10.1016/j.heliyon.2022.e10152
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Effect of volume of [C4mim] BF4.
Figure 2(a). Effect of concentration of NaOH solutions (M). (b). Effect of volume of NaOH solutions.
Figure 3Effect of the ionic strength.
Quantitative characteristics of the proposed RP-IL-DLLME method for the analysis of DA in the urine sample (n = 5).
| Concentration (ng mL −1) | Precision (RSD%) | Accuracy (%) | Recovery (%) | ||
|---|---|---|---|---|---|
| Intra-day | Inter-day | Intra-day | Inter-day | ||
| 0.1 | 3.3 | 3.9 | 94.8 | 95.6 | 94.6 |
| 1.0 | 2.9 | 3.5 | 95.9 | 96.4 | 95.9 |
| 10.0 | 1.9 | 2.6 | 96.3 | 97.6 | 97.3 |
Stability f or the assay of DA in urine sample (n = 5).
| Concentration found (ng mL−1) (mean ± SD) | Concentration added (ng mL−1) (mean ± SD) | ||
|---|---|---|---|
| 0.1 | 1.0 | 10.0 | |
| Freeze and thaw stability | |||
| At the beginning | 0.0946 ± 0.0061 | 0.959 ± 0.047 | 9.68 ± 0.35 |
| After three freeze-thaw cycle | 0.0990 ± 0.0065 | 0.995 ± 0.052 | 10.01 ± 0.57 |
| Bias (RE%) | 4.6 | 3.8 | 3.4 |
| Short-term room temperature stability | |||
| At the beginning | 0.0946 ± 0.0061 | 0.959 ± 0.047 | 9.68 ± 0.35 |
| After 4 h at room temperature | 0.0983 ± 0.0042 | 0.991 ± 0.042 | 9.90 ± 0.46 |
| Bias (RE%) | 3.9 | 3.4 | 2.3 |
| Long-term cold storage stability | |||
| At the beginning | 0.0946 ± 0.0061 | 0.959 ± 0.047 | 9.68 ± 0.35 |
| After 15 days at -20 °C | 0.1004 ± 0.0039 | 1.012 ± 0.038 | 10.12 ± 0.42 |
| Bias (RE%) | 6.1 | 5.5 | 4.5 |
a Bias (RE%)= (Cactual −Ccalculated)/Cactual (%).
Comparison of the present study with traditional RP-DLLME methods for the determination of DA.
| Sample preparation | LOD (ng mL-1) | LR (ng mL-1) | RSD % | EF |
|---|---|---|---|---|
| RP-IL-DLLME | 0.03 | 0.1–10 | ≤3.3 | 230 |
| RP-DLLME | 0.31 | 1–100 | ≤9.7 | 86 |
EF, enrichment factor; LR, linear range.
Comparison of the present study with some recent methods selected from the literature for the determination of DA.
| Samples | Methods | Sample preparation | LOD | LR | Time (min) | RSD % | Refs |
|---|---|---|---|---|---|---|---|
| Shellfish | ELISA | LLE | ≥25 ng g−1 | 25–500 ng g−1 | >120 | ≤4.12 | [ |
| mussels | HPLC/PCD | SPE | ≥25 ng mL−1 | 50–1500 ng mL−1 | >25 | ≤1.9 | [ |
| seawater | RRLC-MS/MS | SPE | ≥0.02 ng mL−1 | 0.1–10.0 ng mL−1 | >10 | ≤19.0 | [ |
| seawater | HPLC/DAD | MIPs-SPE | ≥0.01 mg mL−1 | 0–50 mg mL−1 | >15 | ≤5.0 | [ |
| Plasma | HPLC-MS/MS | LLE | ≥0.16 ng mL−1 | 0.16–16 ng mL−1 | >> 60 | ≤7.3 | [ |
| Urine | HPLC-MS/MS | LLE | ≥7.8 ng mL−1 | 7.8–1000 ng mL−1 | >> 15 | ≤11.4 | [ |
| urine | UHPLC/DAD | RP-IL-DLLME | ≥0.03 ng mL−1 | 0.1–10.0 ng mL−1 | <10 | ≤6.4 | Present method |
ELISA: enzyme-linked immunosorbent assa.
HPLC-PCD: high-performance liquid chromatography/post-column derivatization.
RRLC-MS/MS: rapid resolution liquid chromatography-tandem mass spectrometry.
HPLC-DAD: high-performance liquid chromatography/diode-array detector.
MIPs: Molecularly imprinted polymers.
Quantification of DA in six human urine samples by RP-IL-DLLME (n = 3).
| Sample | DA (mean ± SD; ng mL−1) |
|---|---|
| 1 | ND |
| 2 | 1.78 ± 0.043 |
| 3 | ND |
| 4 | ND |
| 5 | ND |
| 6 | 0.15 ± 0.028 |
Figure 4UHPLC-UV chromatogram of (a) human blank urine and (b) spiked urine sample (1.0 ng mL−1) of DA extracted by RP-IL-DLLME.